LQDA NASDAQ
Liquidia Corporation
1W: +4.5%
1M: +67.2%
3M: +84.5%
YTD: +97.4%
1Y: +264.1%
3Y: +725.2%
5Y: +2178.3%
$60.98
-0.99 (-1.60%)
Weekly Expected Move ±14.0%
$41
$49
$57
$65
$73
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
0.90
Bullish
2 bullish
0 neutral
0 bearish
Articles (24h)
2
Hourly Sentiment (24h)
0.84
Bullish
15 bullish
1 neutral
0 bearish
Articles (7d)
16
Daily Sentiment (7 Days)
Articles (100)
Here's Why You Should Add Altimmune Stock to Your Portfolio Now
TEVA's MAA for Olanzapine LAI in Schizophrenia Accepted in the EU
Dyne Stock Gains 10% on Initiation of Late-Stage Study in DMD Patients
Is it a Good Idea to Invest in Stoke Therapeutics Stock Now?
Zacks.com featured highlights include Liquidia, Exxon Mobil, Valero Energy and Diamondback Energy
ATRA Stock Shoots Up 82% in a Month: Here's What You Should Know
IMVT's Q4 Loss Wider Than Expected, Stock Up 35% on Strong Study Data
4 Low-Beta Stocks for a Steadier Portfolio: LQDA, XOM, VLO & FANG
TGTX Stock Rises 29% in 3 Months: Here's What You Should Know
ERNA Stock Shoots Up 140% in a Month: Here's What You Should Know
Merck's ADC Candidate Meets Goals in Endometrial Cancer Study
FDA Accepts Viatris' NDA for Fast-Acting Non-Opioid Pain Therapy
FDA Grants Priority Tag to Bayer's Oncology Drug for First-Line NSCLC
Bayer Gets FDA Priority Review for Asundexian NDA in Stroke Prevention
AZN, Daiichi's Enhertu Gets FDA Nod for Two New Breast Cancer Settings
AstraZeneca Gets FDA Nod for New Hypertension Drug Baxfendy
Keros Q1 Loss Wider Than Expected, Revenues Plunge Year Over Year
Earnings Estimates Moving Higher for Liquidia Corporation (LQDA): Time to Buy?
ESPR Stock Surges 44% in a Month: Here's What You Need to Know
Altimmune's Q1 Loss Narrower Than Expected, Revenues Nil
What to Know About This Fund’s $15.5 Million Sale of Liquidia as Shares Skyrocket Nearly 260%
Agios Seeks FDA Nod to Expand Mitapivat Label in Sickle Cell Disease
Best Momentum Stocks to Buy for May 13th
New Strong Buy Stocks for May 13th
These Analysts Boost Their Forecasts On Liquidia After Upbeat Q1 Results
Liquidia (LQDA) Q1 2026 Earnings Transcript
BDTX Shares Gain 11% in a Week: Here's What You Should Know
Liquidia Corporation (LQDA) Surpasses Q1 Earnings and Revenue Estimates
Liquidia Corporation Reports First Quarter 2026 Financial Results
Liquidia Corporation Reports First Quarter 2026 Financial Results
Here are the major earnings before the open Monday
This Biotech Stock Has Soared 175%. Here’s Why One Fund Still Sold $3 Million Worth
Xenon Q1 Earnings Match Estimates, Pipeline Development in Focus
Kodiak's Q1 Loss Wider Than Expected, Pipeline Development in Focus
BEAM's Q1 Loss Wider Than Expected, Revenues Beat Estimates
Best Low-Beta Stocks to Own Right Away: LQDA, CBOE, VLO & FANG
Alector (ALEC) Reports Q1 Loss, Lags Revenue Estimates
Viatris Q1 EPS Beats Estimates, Revenues up 8% Driven by Greater China
ADMA Q1 EPS Jumps 73% Y/Y, Revenues Slip, 2026 View Down
Liquidia Corporation to Participate in Upcoming Investor Conferences
New Strong Buy Stocks for May 6th
Liquidia Corporation (LQDA): Billionaire Tom Steyer Admires This Pharma Stock
Summers Value Fund adds TBPH, exits ADMA among Q1 moves
Liquidia's (LQDA) CEO Sells 53,000 Shares for $2.1 Million
Insider Selling: Liquidia (NASDAQ:LQDA) CEO Sells $1,003,500.00 in Stock
Insider Selling: Liquidia (NASDAQ:LQDA) CFO Sells $5,595,114.60 in Stock
Liquidia (NASDAQ:LQDA) Shares Down 7.9% After Insider Selling
Tudor Investment Corp ET AL Makes New Investment in Liquidia Corporation $LQDA
Interstitial Lung Disease Market to Witness Accelerated Growth at a CAGR of 8.7% During the Forecast Period (2026–2036) Due to the Launch of Emerging Therapies | DelveInsight
Liquidia Corporation to Participate in Upcoming Investor Conferences
Liquidia Corporation to Participate in Upcoming Investor Conferences
SG Americas Securities LLC Acquires 17,407 Shares of Liquidia Corporation $LQDA
Liquidia Corporation (NASDAQ:LQDA) Given Average Rating of “Moderate Buy” by Brokerages
Liquidia's Chairman Sold Company Shares Worth $2.5 Million. Should Investors Avoid the Stock?
Does Liquidia Corporation (LQDA) Have the Potential to Rally 34.47% as Wall Street Analysts Expect?
Liquidia (NASDAQ:LQDA) Director Stephen Bloch Sells 62,550 Shares
AZN Posts Data From Hypophosphatasia Program on Efzimfotase Alfa
AZN Posts Data From Hypophosphatasia Program on Efzimfotase Alfa
Sanofi Gets EU Nod for Rezurock in Chronic Graft-Vs-Host Disease
Tudor Investment Corp ET AL Makes New $1.54 Million Investment in Liquidia Corporation $LQDA
The Chief Commercial Officer of Liquidia (LQDA) Sold 80,000 Shares for $2.8M
Novartis Bolsters Immunology Pipeline With Excellergy Deal
Scott Moomaw Sells 18,314 Shares of Liquidia (NASDAQ:LQDA) Stock
Indivior, Liquidia, Crinetics top Quant pharma list as Merck scoops up Terns for $6.7B
Liquidia Stock Up 135% as Insider Sells $1.3 Million in Shares
FDA Approves BMY's Opdivo Label Expansion in Classical Hodgkin Lymphoma
GSK's Risvutatug Rezetecan Gets Japan Orphan Drug Tag for Lung Cancer
Novartis Strikes $3B Oncology Deal for Breast Cancer Asset
Best Low-Beta Stocks to Own Right Away: AGRO, PRA, E & LQDA
Can Liquidia Corporation (LQDA) Run Higher on Rising Earnings Estimates?
Wall Street Analysts See a 35.35% Upside in Liquidia Corporation (LQDA): Can the Stock Really Move This High?
Zacks Industry Outlook Highlights Terns Pharmaceuticals, ADMA Biologics, ANI Pharmaceuticals and Liquidia
420,800 Shares in Liquidia Corporation $LQDA Bought by Apis Capital Advisors LLC
Mid-Cap healthcare stocks ranked by quant ratings after earnings season
4 Biotech Stocks to Watch for Potential Upside in 2026
Nektar Q4 Earnings & Revenues Trump Estimates, Pipeline in Focus
Liquidia Corporation (NASDAQ:LQDA) Receives Average Recommendation of “Moderate Buy” from Analysts
Best Momentum Stocks to Buy for March 10th
Research Analysts Offer Predictions for Liquidia Q1 Earnings
Liquidia (NASDAQ:LQDA) Trading Up 7% on Analyst Upgrade
Liquidia Analysts Boost Their Forecasts After Q4 Earnings
Liquidia (NASDAQ:LQDA) Shares Gap Down Following Weak Earnings
FY2025 EPS Estimates for Liquidia Increased by HC Wainwright
Liquidia (LQDA) Q4 2025 Earnings Call Transcript
Liquidia targets $1B franchise in 2027 as YUTREPIA surges to 17% Q4 market share
Liquidia Corporation (LQDA) Surpasses Q4 Earnings and Revenue Estimates
Liquidia GAAP EPS of $0.15 misses by $0.05, revenue of $92.02M beats by $4.53M
Liquidia Q4 Earnings Summary & Key Takeaways
Liquidia Corporation Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Liquidia Corporation Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Earnings Scheduled For March 5, 2026
HC Wainwright Forecasts Liquidia FY2030 Earnings
Here are the major earnings before the open Thursday
Investment Manager Sells $5.1 Million Worth of LQDA Stock, According to Recent SEC Filing
Liquidia FY 2025 Earnings Preview
A Peek at Liquidia's Future Earnings
Liquidia Appears Set For Strong 2026 On Further Share Gains
Liquidia Corporation to Report Full Year 2025 Financial Results on March 5, 2026
MannKind, Liquidia fall as United Therapeutics mulls new treprostinil formulation
Liquidia (NASDAQ:LQDA) Trading Down 5% – Here’s Why